SCHEMBL26178673

SCHEMBL26178673

Bc1ccc(C(=O)N(C)CCC)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.40
HSP90AA1 P07900 3/20 0.39
TP53 P04637 1/20 0.39
SPR P35270 1/20 0.38
PDK2 Q15119 1/20 0.38
ACACB O00763 2/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 3/20 0.36
CYP1A2 P05177 1/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
NAMPT P43490 2/20 0.36
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
PDE11A Q9HCR9 1/20 0.34
MLYCD O95822 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26730051 0.83 HCAR3 (0.46) KMT2APDK2SMN1; SMN2THRATHRB
SCHEMBL2228382 0.78 KMT2A (0.63) KMT2AHSP90AA1TP53SMN1; SMN2HPGD
SCHEMBL471656 0.78 HPGD (0.50) KMT2AHSP90AA1SMN1; SMN2HPGDCYP1A2
SCHEMBL16915230 0.76 MCHR1 (0.47) KMT2ASMN1; SMN2THRATHRBHPGD
SCHEMBL20858882 0.74 TSHR (0.45) KMT2AHSP90AA1PDK2SMN1; SMN2THRA
SCHEMBL16994787 0.72 SMN1; SMN2 (0.51) KMT2AHSP90AA1PDK2HTTSMN1; SMN2
SCHEMBL10282503 0.72 SMN1; SMN2 (0.48) KMT2AHSP90AA1HTTSMN1; SMN2HPGD
SCHEMBL4518825 0.72 KMT2A (0.41) KMT2AHSP90AA1PDK2HTTSMN1; SMN2
SCHEMBL12213211 0.71 SMN1; SMN2 (0.50) KMT2AHSP90AA1HTTSMN1; SMN2HPGD
SCHEMBL26730049 0.71 HSP90AA1 (0.36) KMT2AHSP90AA1SPRPDK2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 KMT2A 1738/4885HSP90AA1 1718/4885TP53 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.